Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia

Predicting individual effects of switching from standard half-life (SHL) to extended half-life (EHL) FVIII/FIX concentrates is pivotal in clinical care, but large-scale individual data are scarce. The aim of this study was to assess individual changes in terminal half-life (THL) after switching to E...

Descripción completa

Detalles Bibliográficos
Autores principales: Versloot, Olav, Iserman, Emma, Chelle, Pierre, Germini, Federico, Edginton, Andrea N., Schutgens, Roger E. G., Iorio, Alfonso, Fischer, Kathelijn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939912/
https://www.ncbi.nlm.nih.gov/pubmed/35356797
http://dx.doi.org/10.1097/HS9.0000000000000694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939912/
https://www.ncbi.nlm.nih.gov/pubmed/35356797
http://dx.doi.org/10.1097/HS9.0000000000000694

Ejemplares similares